DuPont de Nemours, Inc.

please press star one again. Thank you. I would now like to turn the call over to Angie and Christopher. Please go ahead.

Good morning, and thank you for joining us for DuPont's third quarter 2025 financial results conference call. Joining me today are Lori Koch, Chief Executive Officer, and Antonella Franzen, Chief Financial Officer. We have prepared slides to supplement our remarks, which are posted on DuPont's website under the investor relations tab and through the webcast link. Please read the forward-looking statement disclaimer contained in the slides. During this call, we will make forward-looking statements regarding our expectations or predictions about the future. Because these statements are based on current assumptions and factors that involve risks and uncertainties, our actual performance and results may differ materially from our forward-looking statements. Our Form 10-K, as updated by our current and periodic reports, includes detailed discussion of principal risk and uncertainties which may cause such differences. Unless otherwise specified, all historical financial measures presented today are on a continuing operations basis and exclude significant items. We will also refer to other non-GAAP measures. A reconciliation to the most directly comparable GAAP financial measure is included in our press release and presentation materials and has been posted to DuPont's investor relations website. As a quick reminder, on the basis of presentation for our third quarter financial results, our total company net sales, operating EBITDA, and adjusted EPS include segment results for electronics co and industrials co excluding results for the previously announced investiture of the aramids business which is now reported as discontinued operation i'll now turn the call over to lori who will begin on slide three good morning and thanks everyone for joining our third quarter call earlier today we reported another solid quarter

ahead of our previously communicated guidance. Third quarter sales of 3.1 billion grew 6% on an organic basis. Operating EBITDA of 840 million increased 6% year over year, resulting in an operating EBITDA margin of 27.3%. As a result of our strong third quarter financial performance and our expected operational improvement, we are raising our full year earnings guidance for the new DuPont. Antonella will provide further details shortly. Third quarter saw organic growth across all businesses with continued strong volume growth in healthcare and water, coupled with strength in electronics driven by AI technology demand in both interconnect solutions and SEMI. Today, we also announced cap allocation updates for the new DuPont, both in the form of a quarterly dividend and a new share repurchase authorization. We declared our initial quarterly dividend under New DuPont in the amount of 20 cents per share in line with our targeted 35 to 45% payout ratio. The board of directors also approved a $2 billion share repurchase authorization under which we expect to quickly launch an ASR in the amount of 500 million. Both of these actions underpin our commitment to a disciplined capital allocation model and are a testament to our financial strength and dedication to delivering value. Earlier this week, we announced the successful completion of the CUNY separation. As a premier pure play technology solutions partner to the semiconductor value chain, CUNY is well positioned to deliver growth and value creation for its shareholders. Turning to slide four, as part of investor day, I outlined a clear strategy for the new DuPont to drive value creation for all our stakeholders. Our strategy is focused around driving above-market organic growth, building a robust business system, deploying a balanced capital allocation model, and consistently delivering results. We are already seeing progress against these value creation drivers. We have successfully repositioned ourselves and have a streamlined portfolio of leading businesses, the majority of which are aligned to secular end markets, which will enable strong organic growth. We saw nice growth in the third quarter, and we continue to expect 2% organic growth for the full year. Our innovation engine continues to deliver. We announced the launch of our latest technology in Tyvek Garment, branded Tyvek Apex. This latest technology for PPE provides enhanced breathability while maintaining the same level of protection and durability. The launch clearly demonstrates how we collaborate with customers and deploy our application development expertise to meet their needs. As I noted at Investor Day, we are driving towards building a robust business system, starting from a strong jump off point with a full suite of tools that are being actively deployed. This quarter, we introduced a core set of enhanced KPIs that are focused on driving improvement for our shareholders, customers, and employees. These KPIs were embedded in a refreshed set of management standards, which has added more visibility, rigor, and structure to ensure we achieve our business objectives. On commercial excellence, we have advanced the framework across commercial enablement, sales effectiveness, and strategic marketing. A key priority was focused on pipeline disciplines. We have designed a more transparent, data-driven process, which links demand generation, opportunity qualification, and conversion metrics to deliver against our growth target. Specifically, within our water business, we have taken a regional approach to the rollout and have improved pipeline rigor in North America and Europe, leading to sizable improvement in our opportunity funnel. We plan to launch in Asia later this quarter. We also continue to drive enhancements in operational excellence. During the quarter, we rolled out an updated set of KPIs aligned with our focus on safety, quality, delivery, and cost. We also refreshed our toolkit around OEE and reliability, which is driving reductions in unplanned downtime and improving our maintenance spend and rent time. On capital allocation, I highlighted earlier the dividend and share repurchase authorization that was approved by our board. In addition, we also announced in late September that we sign an agreement to acquire manufacturing capacity to expand our reverse osmosis footprint in China. This aligns with our local for local strategy and increases our capacity to meet growing demand for industrial water purification and reuse in the region. With this backdrop, I remain confident in delivering the medium term targets for 26 through 28 that we outlined for you at investor day. 3 to 4% organic growth, 150 to 200 basis points of margin expansion, 8 to 10% EPS growth, and generating strong free cash flow conversion at greater than 90%. With that, I'll now turn the call over to Antonella to cover the financials and outlook.